Skip to main content
×
×
Home

Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial

  • Marco Menchetti (a1), Paola Rucci (a2), Biancamaria Bortolotti (a1), Annarosa Bombi (a1), Paolo Scocco (a3), Helena Chmura Kraemer (a4), Domenico Berardi (a1) and the DEPICS group...
Abstract
Background

Despite depressive disorders being very common there has been little research to guide primary care physicians on the choice of treatment for patients with mild to moderate depression.

Aims

To evaluate the efficacy of interpersonal counselling compared with selective serotonin reuptake inhibitors (SSRIs), in primary care attenders with major depression and to identify moderators of treatment outcome.

Method

A randomised controlled trial in nine centres (DEPICS, Australian New Zealand Clinical Trials Registry number: ACTRN12608000479303). The primary outcome was remission of the depressive episode (defined as a Hamilton Rating Scale for Depression score 7 at 2 months). Daily functioning was assessed using the Work and Social Adjustment Scale. Logistic regression models were used to identify moderators of treatment outcome.

Results

The percentage of patients who achieved remission at 2 months was significantly higher in the interpersonal counselling group compared with the SSRI group (58.7% v. 45.1%, P = 0.021). Five moderators of treatment outcome were found: depression severity, functional impairment, anxiety comorbidity, previous depressive episodes and smoking habit.

Conclusions

We identified some patient characteristics predicting a differential outcome with pharmacological and psychological interventions. Should our results be confirmed in future studies, these characteristics will help clinicians to define criteria for first-line treatment of depression targeted to patients' characteristics.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial
      Available formats
      ×
Copyright
Corresponding author
Marco Menchetti, Institute of Psychiatry, University of Bologna, Viale C. Pepoli 5, 40123 Bologna, Italy. Email: marco.menchetti3@unibo.it
Footnotes
Hide All

This study was funded by the Italian Ministry for University and Research as Research Program of National Interest in 2005 (Prot. 2005063749).

Declaration of interest

None.

Footnotes
References
Hide All
1 Spitzer, RL, Kroenke, K, Linzer, M, Hahn, SR, Williams, JB, deGruy, FV 3rd, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 1995; 274: 1511–7.
2 Üstun, TB, Ayuso-Mateos, JL, Chatterji, S, Mathers, C, Murray, CJL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386–92.
3 Fernández, A, Bellón, Saameño JA, Pinto-Meza, A, Luciano, JV, Autonell, J, Palao, D, et al. Burden of chronic physical conditions and mental disorders in primary care. Br J Psychiatry 2010; 196: 302–9.
4 Lerner, D, Adler, DA, Chang, H, Lapitsky, L, Hood, MY, Perissinotto, C, et al. Unemployment, job retention, and productivity loss among employees with depression. Psychiatr Serv 2004; 55: 1371–8.
5 Davidson, JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry 2010; 71 (suppl E1): e04.
6 American Psychiatric Association. Practice Guideline for the Treatment of Major Depression Disorder. APA, 2000.
7 National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression In Adults. Clinical Guideline 90. NICE, 2009.
8 Kessler, RC, Berglund, P, Demler, O, Jin, R, Koretz, D, Merikangas, KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity SurveyReplication (NCS-R). JAMA 2003; 289: 3095–105.
9 Simon, GE, Perlis, RH. Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 2010; 167: 1445–55.
10 Papakostas, GI, Fava, M. Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder. Dialogues Clin Neurosci 2008; 10: 439–51.
11 Frank, E, Cassano, GB, Rucci, P, Thompson, WK, Kraemer, HC, Fagiolini, A, et al. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med 2011; 41: 151–62.
12 De Rubeis, RJ, Hollon, SD, Amsterdam, JD, Shelton, RC, Young, PR, Salomon, RM, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005; 62: 409–16.
13 Dimidjian, S, Hollon, SD, Dobson, KS, Schmaling, KB, Kohlenberg, RJ, Addis, ME, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 2006; 74: 658–70.
14 Kocsis, JH, Leon, AC, Markowitz, JC, Manber, R, Arnow, B, Klein, DN, et al. Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiatry 2009; 70: 354–61.
15 Fournier, JC, DeRubeis, RJ, Shelton, RC, Hollon, SD, Amsterdam, JD, Gallop, R. Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol 2009; 77: 775–87.
16 Menchetti, M, Bortolotti, B, Rucci, P, Scocco, P, Bombi, A, Berardi, D, et al. Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design. BMC Psychiatry 2010; 10: 97.
17 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM-IV). APA, 1994.
18 Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59 (suppl 20): 2233.
19 Hamilton, M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278–96.
20 Klerman, GL, Weissman, MM, Rounsaville, BJ, Chevron, E. Interpersonal Psychotherapy of Depression. Basics Books, 1984.
21 Klerman, GL, Budman, S, Berwick, D, Weissman, MM, Damico-White, J, Demby, A, et al. Efficacy of a brief psychosocial intervention for symptoms of stress and distress among patients in primary care. Med Care 1987; 25: 1078–88.
22 Mossey, JM, Knott, KA, Higgins, M, Talerico, K. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci 1996; 51: M172–8.
23 Neugebauer, R, Kline, J, Bleiberg, K, Baxi, L, Markowitz, JC, Rosing, M, et al. Preliminary open trial of interpersonal counseling for subsyndromal depression following miscarriage. Depress Anxiety 2007; 24: 219–22.
24 Mundt, JC, Marks, IM, Shear, MK, Greist, JH. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002; 180: 461–4.
25 Thase, ME, Entsuah, AR, Rudolph, RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234–41.
26 McPartlin, GM, Reynolds, A, Anderson, C. A comparison of once daily venlafaxine XR and paroxetine in depressed outpatients treated in general practice. Primary Care Psychiatry 1998; 4: 127–32.
27 Mynors-Wallis, LM, Gath, DH, Day, A, Baker, F. Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care. BMJ 2000; 320: 2630.
28 Kraemer, HC, Wilson, GT, Fairburn, CG, Agras, WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59: 877–83.
29 Pincus, T, Miles, C, Froud, R, Underwood, M, Carnes, D, Taylor, S. Methodological criteria for the assessment of moderators in systematic reviews of randomised controlled trials: a consensus study. BMC Med Res Methodol 2011; 11: 14.
30 Sun, X, Briel, M, Busse, J, You, J, Akl, E, Mejza, F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ 2012; 344: e1553.
31 Kraemer, HC, Kupfer, DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006; 59: 990–6.
32 Mynors-Wallis, LM, Gath, DH, Lloyd-Thomas, AR, Tomlinson, D. Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 1995; 310: 441–5.
33 Brown, C, Schulberg, HC, Madonia, MJ, Shear, MK, Houck, PR. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996; 153: 1293–300.
34 Chilvers, C, Dewey, M, Fielding, K, Gretton, V, Miller, P, Palmer, B, et al. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322: 772–5.
35 Bortolotti, B, Menchetti, M, Bellini, F, Montaguti, MB, Berardi, D. Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. Gen Hosp Psychiatry 2008; 30: 293302.
36 Brown, C, Schulberg, HC, Prigerson, HG. Factors associated with symptomatic improvement and recovery from major depression in primary care patients. Gen Hosp Psychiatry 2000; 22: 242–50.
37 You, S, Conner, KR. Stressful life events and depressive symptoms: influences of gender, event severity, and depression history. J Nerv Ment Dis 2009; 197: 829–33.
38 Salminen, JK, Karlsson, H, Hietala, J, Kajander, J, Aalto, S, Markkula, J, et al. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study. Psychother Psychosom 2008; 77: 351–7.
39 Hegerl, U, Hautzinger, M, Mergl, R, Kohnen, R, Schütze, M, Scheunemann, W, et al. Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm. Int J Neuropsychopharmacol 2010; 13: 3144.
40 Brookes, S, Whitely, E, Egger, M, Davey, Smith G, Mulheran, P, Peters, T. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol 2004; 57: 229–36.
41 Van, HL, Schoevers, RA, Dekker, J. Predicting the outcome of antidepressants and psychotherapy for depression: a qualitative, systematic review. Harv Rev Psychiatry 2008; 16: 225–34.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×
Type Description Title
PDF
Supplementary materials

Menchetti et al. supplementary material
Supplementary Material

 PDF (45 KB)
45 KB

Metrics

Altmetric attention score

Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial

  • Marco Menchetti (a1), Paola Rucci (a2), Biancamaria Bortolotti (a1), Annarosa Bombi (a1), Paolo Scocco (a3), Helena Chmura Kraemer (a4), Domenico Berardi (a1) and the DEPICS group...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *